HomeLUMO • NASDAQ
add
Lumos Pharma Inc
Previous close
$4.33
Day range
$4.30 - $4.40
Year range
$1.37 - $4.58
Market cap
37.28M USD
Avg Volume
106.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 726.00K | 10,271.43% |
Operating expense | 8.37M | -6.41% |
Net income | -7.47M | 10.04% |
Net profit margin | -1.03K | 99.13% |
Earnings per share | -0.90 | 13.46% |
EBITDA | -7.64M | 14.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.52M | -68.34% |
Total assets | 17.46M | -63.43% |
Total liabilities | 12.55M | 2.35% |
Total equity | 4.91M | — |
Shares outstanding | 8.65M | — |
Price to book | 7.60 | — |
Return on assets | -98.41% | — |
Return on capital | -241.62% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.47M | 10.04% |
Cash from operations | -5.01M | 35.98% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 1.73M | 496.78% |
Net change in cash | -3.28M | -42.30% |
Free cash flow | -2.32M | 53.82% |
About
Founded
1999
Headquarters
Website
Employees
30
